Resumo oficial · English
O que está a ser adquirido?
The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectiv
Fonte e fiabilidade
Fonte: anúncio oficial do TED 500469-2026, verificado pela última vez em 21 de ago de 2026 14:05. A publicação original continua a ser a referência.
Os dados são reorganizados para facilitar a leitura. O anúncio oficial e os documentos do concurso prevalecem sempre.